{"disease":{"id":"colon-cancer","name":"colon cancer"},"drugs":{"marketed":[{"drug_id":"trastuzumab","indication_name":"HER2-positive colon cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Herceptin","generic_name":"trastuzumab","company_name":"Roche","drug_phase":"marketed","molecular_target":"HER2 receptor, subdomain IV","drug_class":"Antibody-drug conjugate (ADC)","quality_score":10,"revenue":"2900","mechanism":"HER2-targeted antibody-drug conjugate delivering microtubule inhibitor DM1 to HER2-overexpressing cells."},{"drug_id":"pertuzumab","indication_name":"HER2-positive colon cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Perjeta","generic_name":"pertuzumab","company_name":"Roche","drug_phase":"marketed","molecular_target":"Receptor tyrosine-protein kinase erbB-2","drug_class":"HER2/neu Receptor Antagonist [EPC]","quality_score":10,"revenue":null,"mechanism":"Pertuzumab targets the extracellular dimerization domain of the HER2 protein, blocking ligand-dependent heterodimerization with other HER family members."},{"drug_id":"folfiri","indication_name":"Adjuvant treatment of colon cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Folfiri","generic_name":"folfiri","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"DNA replication and repair","drug_class":"chemotherapy","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"trastuzumab-dkst","indication_name":"HER2-positive colon cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"OGIVRI","generic_name":"TRASTUZUMAB-DKST","company_name":"MYLAN GMBH","drug_phase":"marketed","molecular_target":"Receptor tyrosine-protein kinase erbB-2","drug_class":"HER2/neu Receptor Antagonist [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"trazimera","indication_name":"HER2-positive colon cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Herceptin","generic_name":"Trastuzumab-Qyyp","company_name":"Roche","drug_phase":"marketed","molecular_target":"HER2 (c-erbB2) proto-oncogene transmembrane receptor protein","drug_class":"HER2/neu receptor antagonist monoclonal antibody","quality_score":10,"revenue":null,"mechanism":"Trastuzumab inhibits proliferation of HER2-overexpressing tumor cells and mediates antibody-dependent cellular cytotoxicity."},{"drug_id":"herceptin","indication_name":"HER2-positive colon cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Herceptin","company_name":"National Cancer Institute (NCI)","drug_phase":"marketed","molecular_target":"Receptor tyrosine-protein kinase erbB-2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"trastuzumab-herceptin","indication_name":"HER2-positive colon cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Trastuzumab (Herceptin)","generic_name":"trastuzumab-herceptin","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Receptor tyrosine-protein kinase erbB-2","drug_class":"","quality_score":25,"revenue":null,"mechanism":null},{"drug_id":"capecitabine","indication_name":"Adjuvant treatment of Stage III colon cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xeloda","generic_name":"capecitabine","company_name":"Cheplapharm","drug_phase":"marketed","molecular_target":"Thymidylate synthase","drug_class":"Nucleoside Metabolic Inhibitor [EPC]","quality_score":67,"revenue":null,"mechanism":"Xeloda works by inhibiting the enzyme thymidylate synthase, which is necessary for DNA synthesis in cancer cells."},{"drug_id":"perjeta","indication_name":"HER2-positive colon cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Perjeta","company_name":"BioRay Pharmaceutical Co., Ltd.","drug_phase":"marketed","molecular_target":"Receptor tyrosine-protein kinase erbB-2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":9,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05434026","title":"Chinese Colorectal Cancer Database","phase":"","overall_status":"RECRUITING","enrollment_count":200000,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT00622557","title":"General Surgical Outcomes Quality Improvement Database (UH-SOCRATES)","phase":"","overall_status":"COMPLETED","enrollment_count":200000,"lead_sponsor_name":"University Hospitals Cleveland Medical Center","has_results":false},{"nct_id":"NCT04651504","title":"Rural Colon Cancer Screening Toolkit Intervention","phase":"NA","overall_status":"COMPLETED","enrollment_count":185903,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT06043947","title":"Survival Monitoring in Russian Cancer Registries","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100000,"lead_sponsor_name":"N.N. Petrov National Medical Research Center of Oncology","has_results":false},{"nct_id":"NCT03843957","title":"Effectiveness and Implementation of mPATH-CRC","phase":"NA","overall_status":"COMPLETED","enrollment_count":77145,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":true},{"nct_id":"NCT04496635","title":"Surveillance and Implementation of a Bundle of Care to Reduce Surgical Site Infection in Colorectal Surgery (CCR-VINCat)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60000,"lead_sponsor_name":"Hospital de Granollers","has_results":false},{"nct_id":"NCT04369053","title":"Prevention of Colorectal Cancer Through Multiomics Blood Testing","phase":"","overall_status":"COMPLETED","enrollment_count":48995,"lead_sponsor_name":"Freenome Holdings Inc.","has_results":true},{"nct_id":"NCT06244836","title":"Comparison of Two Bundles of Care to Reduce Surgical Site Infection in Colorectal Surgery (CCR-VINCat 2)","phase":"NA","overall_status":"COMPLETED","enrollment_count":32205,"lead_sponsor_name":"Hospital de Granollers","has_results":false},{"nct_id":"NCT06640426","title":"Messaging Intervention to Increase Medicare Annual Wellness Visits -- The NUDGE AWV Clinical Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":29842,"lead_sponsor_name":"Emily Rosenzweig","has_results":false},{"nct_id":"NCT05142033","title":"Avera Cancer Sequencing and Analytics Protocol (ASAP)","phase":"","overall_status":"RECRUITING","enrollment_count":25000,"lead_sponsor_name":"Avera McKennan Hospital & University Health Center","has_results":false},{"nct_id":"NCT04540081","title":"Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":20000,"lead_sponsor_name":"University of California, Davis","has_results":false},{"nct_id":"NCT03958435","title":"Real-world Retrospective Data Analysis of Adjuvant Therapy for Patients With Stage II-III Colon Cancer After Radical Surgery","phase":"","overall_status":"UNKNOWN","enrollment_count":20000,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT03471494","title":"GlobalSurg 3: Quality and Outcomes in Global Cancer Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":15958,"lead_sponsor_name":"University of Edinburgh","has_results":false},{"nct_id":"NCT05174845","title":"Real Word Evidence With 1L Polyethylene Glycol (PEG)+ Ascorbic Acid in Iberia","phase":"","overall_status":"COMPLETED","enrollment_count":13393,"lead_sponsor_name":"Norgine","has_results":false},{"nct_id":"NCT07167147","title":"Survival Outcomes by Tumor-Node Stage and Recurrence Patterns in Colon Cancer After Radical Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":7259,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT03361904","title":"Colonoscopic Adenoma and Advanced Neoplasia Detection Rates According to Age","phase":"","overall_status":"COMPLETED","enrollment_count":6027,"lead_sponsor_name":"Société Française d'Endoscopie Digestive","has_results":false},{"nct_id":"NCT05341622","title":"Mailed FIT Outreach 2022","phase":"NA","overall_status":"COMPLETED","enrollment_count":5460,"lead_sponsor_name":"Abramson Cancer Center at Penn Medicine","has_results":true},{"nct_id":"NCT02595957","title":"Genomic Services Research Program","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"National Human Genome Research Institute (NHGRI)","has_results":false},{"nct_id":"NCT07143487","title":"Family Communications After Genetic Testing","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":4186,"lead_sponsor_name":"Alliance for Clinical Trials in Oncology","has_results":false},{"nct_id":"NCT06684223","title":"Analysis of Surgical and Oncologic Outcomes After Complete Mesocolic Excision or Non-complete Mesocolic Excision for Right-Sided Colon Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":3787,"lead_sponsor_name":"Asan Medical Center","has_results":false},{"nct_id":"NCT02938481","title":"International Prospective Observational Cohort Study for Optimal Bowel Resection Extent and Central Radicality for Colon Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":3647,"lead_sponsor_name":"Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan","has_results":false},{"nct_id":"NCT06865586","title":"A Comparative Study of Tumor Specific Mesocolic Excision and Complete Mesocolic Excision for Right Sided Colon Cancer : Asian Multicenter Retrospective Study","phase":"","overall_status":"COMPLETED","enrollment_count":3326,"lead_sponsor_name":"Asan Medical Center","has_results":false},{"nct_id":"NCT01647776","title":"Screening and Risk Factors of Colon Neoplasia","phase":"","overall_status":"COMPLETED","enrollment_count":3315,"lead_sponsor_name":"Case Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT06653478","title":"Development and Demonstration of Intelligent Assessment Based on Multi-modal Information Fusion for Tumor Risk and Diagnosis and Treatment","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT00096278","title":"Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2710,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT05529615","title":"Circulating Tumor DNA Guided Adjuvant Chemotherapy for Colon Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":2684,"lead_sponsor_name":"Peking University Cancer Hospital & Institute","has_results":false},{"nct_id":"NCT07012538","title":"RASi for Preventing Postoperative Recurrence of Stage II/III Colon Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":2640,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT06924931","title":"Five-year Recurrence After LCME","phase":"","overall_status":"COMPLETED","enrollment_count":2529,"lead_sponsor_name":"Gødstrup Hospital","has_results":false},{"nct_id":"NCT01547845","title":"Cancer Symptom Data From Multiple Treatment Centers","phase":"","overall_status":"COMPLETED","enrollment_count":2517,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03702309","title":"Liquid Biopsy Evaluation and Repository Development at Princess Margaret","phase":"","overall_status":"RECRUITING","enrollment_count":2500,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT07494201","title":"MIMICC Study in Patients With Colorectal Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":2500,"lead_sponsor_name":"Fondazione del Piemonte per l'Oncologia","has_results":false},{"nct_id":"NCT06268379","title":"BMA and Dynamic Nomogram for Survival Prediction in Patients With CRC","phase":"","overall_status":"COMPLETED","enrollment_count":2475,"lead_sponsor_name":"Cabrini Health","has_results":false},{"nct_id":"NCT00217737","title":"Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2431,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT06134089","title":"Evaluating Online Messages About Colon Cancer Screening","phase":"","overall_status":"COMPLETED","enrollment_count":2210,"lead_sponsor_name":"University of Utah","has_results":true},{"nct_id":"NCT06009484","title":"VTE Incidence After Curative Colon Cancer Surgery in an ERAS Program","phase":"","overall_status":"COMPLETED","enrollment_count":2141,"lead_sponsor_name":"Nordsjaellands Hospital","has_results":false},{"nct_id":"NCT06710509","title":"Patient Reminders Optimizing Mail-in Prevention Testing for Colorectal Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":2106,"lead_sponsor_name":"Emily Rosenzweig","has_results":false},{"nct_id":"NCT05987709","title":"Study of Colorectal Cancer Screening Options","phase":"NA","overall_status":"COMPLETED","enrollment_count":2004,"lead_sponsor_name":"Kaiser Permanente","has_results":true},{"nct_id":"NCT05726188","title":"Predictors of Disease Recurrence After Curative Surgery for Stage I Colon Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Azienda Ospedaliera Universitaria Integrata Verona","has_results":false},{"nct_id":"NCT06216405","title":"Performance of Artificial Intelligence in Colonoscopy for Right Colon Polyp Detection","phase":"NA","overall_status":"COMPLETED","enrollment_count":2000,"lead_sponsor_name":"Groupe Hospitalier Diaconesses Croix Saint-Simon","has_results":false},{"nct_id":"NCT05174169","title":"Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":1912,"lead_sponsor_name":"NRG Oncology","has_results":false},{"nct_id":"NCT06454253","title":"Short- and Long-term Outcomes of Robotic vs Laparoscopic Right Colon Cancer: a 10-year Single-center Retrospective Study","phase":"","overall_status":"COMPLETED","enrollment_count":1879,"lead_sponsor_name":"Taiyuan Li","has_results":false},{"nct_id":"NCT04235556","title":"Integrated Care Pathway in Oncology (PASSION)","phase":"","overall_status":"UNKNOWN","enrollment_count":1800,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05030870","title":"Capnographic Monitoring in Gastrointestinal Endoscopy for Elderly Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":1800,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT06116864","title":"Enchasing Polyp Detection: The Effect of Adding Polyp Detection Attachment Device to Computer Aid Detection System.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":1766,"lead_sponsor_name":"Marshall University","has_results":false},{"nct_id":"NCT00034216","title":"Collection of Blood From Patients With Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":1750,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT05643105","title":"Anastomotic Leakage After Colon Cancer Surgery","phase":"","overall_status":"UNKNOWN","enrollment_count":1628,"lead_sponsor_name":"Hospital San Carlos, Madrid","has_results":false},{"nct_id":"NCT04628182","title":"The China Laparoscopic Right Hemicolectomy SNAPSHOT","phase":"","overall_status":"UNKNOWN","enrollment_count":1579,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT07380464","title":"A New Classification System for Lymph Nodes in Colon Cancer: The Prognostic Significance of the Anatomical Distribution of Metastatic Lymph Nodes and the Number of Tumor Deposits","phase":"","overall_status":"COMPLETED","enrollment_count":1500,"lead_sponsor_name":"Cai Zerong","has_results":false},{"nct_id":"NCT04478851","title":"EXCEL: Exercise for Cancer to Enhance Living Well","phase":"NA","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"University of Calgary","has_results":false},{"nct_id":"NCT06179602","title":"Prospective Cohort Study on Thermal Ablation of Malignant Liver Tumors","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"Leiden University Medical Center","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}